
PHOENIX INTERNATIONAL LIFE SCIENCES — Investor Relations & Filings
Phoenix International Life Sciences operates as an adaptive healthcare solutions company focused on advancing research, integrating programs, and manufacturing specialized products. The company targets therapeutic areas including diabetes, pain management, and oncology. Its strategy involves combining innovative at-home medical test kits, AI-driven analytics, and cutting-edge clinical research to deliver disruptive healthcare solutions. The firm also develops and acquires intellectual property related to cannabinoid treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2000-07-20 | English | |
| Other Correspondence.PDF | 2000-02-24 | English | |
| Other Correspondence.PDF | 2000-02-15 | English | |
| Other Correspondence.PDF | 2000-02-15 | English | |
| Other Correspondence.PDF | 2000-02-14 | English | |
| Other Correspondence.pdf | 2000-02-10 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2000
8 filings
| |||||
| 47734710 | Material change report - English.pdf | 2000-07-20 | English | ||
| 47734715 | Other Correspondence.PDF | 2000-02-24 | English | ||
| 47734718 | Other Correspondence.PDF | 2000-02-15 | English | ||
| 47734759 | Other Correspondence.PDF | 2000-02-15 | English | ||
| 47734763 | Other Correspondence.PDF | 2000-02-14 | English | ||
| 47734766 | Other Correspondence.pdf | 2000-02-10 | English | ||
| 47734824 | Other Correspondence.pdf | 2000-02-10 | English | ||
| 47734828 | Other.pdf | 2000-01-19 | English | ||
|
1999
7 filings
| |||||
| 47734832 | Other.W61 | 1999-06-03 | English | ||
| 47734836 | Other Correspondence.w52 | 1999-04-13 | English | ||
| 47734840 | Relief/Approval.w51 | 1999-03-17 | English | ||
| 47734981 | Other Correspondence.w61 | 1999-03-12 | English | ||
| 47734985 | Other Correspondence.w51 | 1999-01-26 | English | ||
| 47735161 | Other Correspondence.w52 | 1999-01-25 | English | ||
| 47735165 | Other Correspondence.W52 | 1999-01-22 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Burning Rock Biotech Ltd
A global diagnostics company specializing in precision onco…
|
BNR | US | Professional, scientific and te… |
|
Cabaletta Bio, Inc.
Develops engineered T cell therapies for B cell-mediated au…
|
CABA | US | Professional, scientific and te… |
|
Caliway
Develops small-molecule therapeutics for medical aesthetics…
|
6919 | TW | Professional, scientific and te… |
|
CALIX LIMITED
Develops industrial carbon capture and sustainable mineral …
|
CXL | AU | Professional, scientific and te… |
|
CAMBIUM BIO LIMITED
Clinical-stage developer of cellular therapies for ophthalm…
|
CMB | AU | Professional, scientific and te… |
|
CAMBRIDGE COGNITION HOLDINGS PLC
Develops digital solutions and a platform for CNS clinical …
|
COG | GB | Professional, scientific and te… |
|
CanBas Co.,Ltd.
A clinical-stage biopharmaceutical company developing novel…
|
4575 | JP | Professional, scientific and te… |
|
Captor Therapeutics S.A.
Develops Targeted Protein Degradation therapies for cancer …
|
CTX | PL | Professional, scientific and te… |
|
Cardiff Oncology, Inc.
A clinical-stage biotech developing cancer therapies that i…
|
CRDF | US | Professional, scientific and te… |
|
Cardio Diagnostics Holdings, Inc.
Develops AI-powered epigenetic and genetic tests for early …
|
CDIO | US | Professional, scientific and te… |
PHOENIX INTERNATIONAL LIFE SCIENCES via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/42595/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=42595 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=42595 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=42595 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 42595}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PHOENIX INTERNATIONAL LIFE SCIENCES (id: 42595)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.